![A, Overall survival (OS) in patients who received 10‐day decitabine... | Download Scientific Diagram A, Overall survival (OS) in patients who received 10‐day decitabine... | Download Scientific Diagram](https://www.researchgate.net/publication/347311399/figure/fig1/AS:1093215809740802@1637654368789/A-Overall-survival-OS-in-patients-who-received-10-day-decitabine-with-venetoclax_Q640.jpg)
A, Overall survival (OS) in patients who received 10‐day decitabine... | Download Scientific Diagram
TRM, Relapse/Progression (1a), Progression Free and Overall Survival... | Download Scientific Diagram
![Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1–Selected NSCLC - ScienceDirect Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1–Selected NSCLC - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1556086421022863-gr1.jpg)
Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1–Selected NSCLC - ScienceDirect
![Frontiers | Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study Frontiers | Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study](https://www.frontiersin.org/files/Articles/858202/fonc-12-858202-HTML/image_m/fonc-12-858202-g001.jpg)
Frontiers | Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study
![Three-year probability of overall survival (OS), disease-free survival... | Download Scientific Diagram Three-year probability of overall survival (OS), disease-free survival... | Download Scientific Diagram](https://www.researchgate.net/publication/237097399/figure/fig3/AS:669276801351688@1536579432420/Three-year-probability-of-overall-survival-OS-disease-free-survival-DFS.png)
Three-year probability of overall survival (OS), disease-free survival... | Download Scientific Diagram
![OS, EFS, Relapse and NRM a Overall Survival (Kaplan-Meïer curves) for... | Download Scientific Diagram OS, EFS, Relapse and NRM a Overall Survival (Kaplan-Meïer curves) for... | Download Scientific Diagram](https://www.researchgate.net/publication/354367091/figure/fig2/AS:1179944671543303@1658332140237/OS-EFS-Relapse-and-NRM-a-Overall-Survival-Kaplan-Meier-curves-for-the-3-groups-of.png)
OS, EFS, Relapse and NRM a Overall Survival (Kaplan-Meïer curves) for... | Download Scientific Diagram
![Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern Years - Biology of Blood and Marrow Transplantation Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern Years - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/attachment/2052561563/2059830314/gr3.jpg)
Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern Years - Biology of Blood and Marrow Transplantation
![Overall survival (OS) amongst patients with AL amyloidosis undergoing... | Download Scientific Diagram Overall survival (OS) amongst patients with AL amyloidosis undergoing... | Download Scientific Diagram](https://www.researchgate.net/publication/334111308/figure/fig1/AS:1093213599342592@1637653841147/Overall-survival-OS-amongst-patients-with-AL-amyloidosis-undergoing-autologous-stem.png)
Overall survival (OS) amongst patients with AL amyloidosis undergoing... | Download Scientific Diagram
![Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis | Leukemia Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2016.229/MediaObjects/41375_2017_Article_BFleu2016229_Fig1_HTML.jpg)
Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis | Leukemia
![Impact of subsequent immune checkpoint inhibitor treatment on overall survival with avelumab vs docetaxel in platinum-treated advanced NSCLC: Post hoc analyses from the phase 3 JAVELIN Lung 200 trial - Lung Cancer Impact of subsequent immune checkpoint inhibitor treatment on overall survival with avelumab vs docetaxel in platinum-treated advanced NSCLC: Post hoc analyses from the phase 3 JAVELIN Lung 200 trial - Lung Cancer](https://www.lungcancerjournal.info/cms/asset/68f093b2-447e-47f4-b550-8cd068c9f718/gr1.jpg)
Impact of subsequent immune checkpoint inhibitor treatment on overall survival with avelumab vs docetaxel in platinum-treated advanced NSCLC: Post hoc analyses from the phase 3 JAVELIN Lung 200 trial - Lung Cancer
![Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults | Blood Cancer Journal Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-020-00373-4/MediaObjects/41408_2020_373_Fig1_HTML.png)
Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults | Blood Cancer Journal
![Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation | Bone Marrow Transplantation Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation | Bone Marrow Transplantation](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41409-019-0469-5/MediaObjects/41409_2019_469_Fig1_HTML.png)
Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation | Bone Marrow Transplantation
![Overall survival (OS) and relative survival by treatment intensity and... | Download Scientific Diagram Overall survival (OS) and relative survival by treatment intensity and... | Download Scientific Diagram](https://www.researchgate.net/publication/341345608/figure/fig2/AS:890712920948738@1589373917224/Overall-survival-OS-and-relative-survival-by-treatment-intensity-and-region-OS-A-and.png)
Overall survival (OS) and relative survival by treatment intensity and... | Download Scientific Diagram
![Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC - Journal of Thoracic Oncology Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC - Journal of Thoracic Oncology](https://www.jto.org/cms/asset/3b4b3b7f-ef3e-49b2-b1e3-89793b6a8627/gr1.jpg)
Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC - Journal of Thoracic Oncology
![Very Young Children Who Undergo Hematopoietic Cell Transplantation at Weight Extremes Have Inferior Overall Survival and Increased Transplant Related Morality - Biology of Blood and Marrow Transplantation Very Young Children Who Undergo Hematopoietic Cell Transplantation at Weight Extremes Have Inferior Overall Survival and Increased Transplant Related Morality - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/asset/c81e7fc1-104b-4bd5-898f-ae85d2a7b38a/gr41.jpg)
Very Young Children Who Undergo Hematopoietic Cell Transplantation at Weight Extremes Have Inferior Overall Survival and Increased Transplant Related Morality - Biology of Blood and Marrow Transplantation
![A, Overall survival (OS) in patients who received 10‐day decitabine... | Download Scientific Diagram A, Overall survival (OS) in patients who received 10‐day decitabine... | Download Scientific Diagram](https://www.researchgate.net/publication/347311399/figure/fig1/AS:1093215809740802@1637654368789/A-Overall-survival-OS-in-patients-who-received-10-day-decitabine-with-venetoclax.png)
A, Overall survival (OS) in patients who received 10‐day decitabine... | Download Scientific Diagram
Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia | Haematologica
![Treatment of Patients with Adult T Cell Leukemia/Lymphoma with Cord Blood Transplantation: A Japanese Nationwide Retrospective Survey - Biology of Blood and Marrow Transplantation Treatment of Patients with Adult T Cell Leukemia/Lymphoma with Cord Blood Transplantation: A Japanese Nationwide Retrospective Survey - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/attachment/2020642845/2040389631/gr1.jpg)
Treatment of Patients with Adult T Cell Leukemia/Lymphoma with Cord Blood Transplantation: A Japanese Nationwide Retrospective Survey - Biology of Blood and Marrow Transplantation
![Favorable Overall Survival with Fully Myeloablative Allogeneic Stem Cell Transplantation for Follicular Lymphoma - Biology of Blood and Marrow Transplantation Favorable Overall Survival with Fully Myeloablative Allogeneic Stem Cell Transplantation for Follicular Lymphoma - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/attachment/543fdedd-4892-4315-99d2-c0ee01315aaa/gr1.gif)
Favorable Overall Survival with Fully Myeloablative Allogeneic Stem Cell Transplantation for Follicular Lymphoma - Biology of Blood and Marrow Transplantation
![Prognostic benefit of stromal and epithelial CD8CD103 TRM infiltration... | Download Scientific Diagram Prognostic benefit of stromal and epithelial CD8CD103 TRM infiltration... | Download Scientific Diagram](https://www.researchgate.net/publication/352175565/figure/fig4/AS:1031879062978561@1623030548093/Prognostic-benefit-of-stromal-and-epithelial-CD8CD103-TRM-infiltration-in-patient.png)
Prognostic benefit of stromal and epithelial CD8CD103 TRM infiltration... | Download Scientific Diagram
![Frontiers | Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation Frontiers | Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation](https://www.frontiersin.org/files/Articles/444876/fimmu-10-01997-HTML/image_m/fimmu-10-01997-g001.jpg)